Compound Summary
Compound Name: | 			Catalpol | 
Compound CID: | 			91520 | 
Synonyms: | 			Catalpol 2415-24-9 Catalpinoside CHEMBL513223 CHEBI:69797 More... | 
Iupac Name: | 			(2S,3R,4S,5S,6R)-2-[[(1S,2S,4S,5S,6R,10S)-5-hydroxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-10-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | 
InChI: | 					InChI=1S/C15H22O10/c16-3-6-9(19)10(20)11(21)14(23-6)24-13-7-5(1-2-22-13)8(18)12-15(7,4-17)25-12/h1-2,5-14,16-21H,3-4H2/t5-,6-,7-,8+,9-,10+,11-,12+,13+,14+,15-/m1/s1 | 
InChIKey: | 				LHDWRKICQLTVDL-PZYDOOQISA-N | 
Canonical Smiles: | 		C1=COC(C2C1C(C3C2(O3)CO)O)OC4C(C(C(C(O4)CO)O)O)O | 
Isomeric Smiles: | 			C1=CO[C@H]([C@H]2[C@@H]1[C@@H]([C@H]3[C@@]2(O3)CO)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O | 
Molecular Weight: | 		362.33 | 
Molecular Formula: | 			C15H22O10 | 
Molecular Weight: | 		362.33 | 
Molecular Formula: | 			C15H22O10 | 
Hydrogen Bond Donor Count: | 			6 | 
Hydrogen Bond Acceptor Count: | 			10 | 
Rotatable Bond Count: | 			4 | 
Heavy Atom Count: | 					25 | 
Complexity: | 				542 | 
| Catalpol | Catalpol | 
|---|---|
Catalpol | 			
2415-24-9 | 
Catalpinoside | 			
CHEMBL513223 | 
CHEBI:69797 | 			
De(p-hydroxybenzoyl)catalposide | 
UNII-JCX5L7JIC2 | 			
JCX5L7JIC2 | 
Catalposide, des-p-hydroxybenzoyl- | 			
EINECS 219-324-0 | 
Digitalis purpurea L | 			
SCHEMBL420515 | 
Catalpol, >=96% (HPLC) | 			
DTXSID60178850 | 
HY-N0820 | 			
ZINC8234298 | 
BDBM50259972 | 			
AKOS024264429 | 
AC-8052 | 			
AM84820 | 
CCG-208299 | 			
LMPR0102070007 | 
NCGC00163523-01 | 			
(1AS-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl-beta-D-glucopyranoside | 
AS-75213 | 			
beta-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy- 1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1aS-(1a-alpha,1b-beta,2-beta,5a-beta,6-beta,6a-alpha))- | 
beta-D-Glucopyranoside, 1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno(4,5)cyclopenta(1,2-c)pyran-2-yl, (1aS-(1aalpha,1bbeta,2beta,5abeta,6beta,6aalpha))- | 			
N1352 | 
SR-05000002315 | 			
Q1050267 | 
SR-05000002315-2 | 			
(1aS,1bS,2S,5aR,6S,6aS)-1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno4,5cyclopenta1,2-cpyran-2-yl beta-D-glucopyranoside | 
(1S,5R,6R)-2-(1S,1bS,2S,5aR,6S)-6-hydroxy-1a-((S)-hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydro-1,3-dioxa-cyclopropaainden-2-yloxy-6-((S)-hydroxymethyl)-tetrahydro-pyran-3,4,5-triol | 			
(2S,3R,4S,5S,6R)-2-(((1aS,1bS,2S,5aR,6S,6aS)-6-hydroxy-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno2,3:4,5cyclopenta1,2-cpyran-2-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol | 
(2S,3R,4S,5S,6R)-2-{(1S,2S,4S,5S,6R,10S)-5-HYDROXY-2-(HYDROXYMETHYL)-3,9-DIOXATRICYCLO4.4.0.0(2),?DEC-7-EN-10-YLOXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL | 			
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 6.250000000000000 | umol/L | NS | N2 | 33683565 | Inactive | |||||||
| Caenorhabditis elegans | 25.000000000000000 | umol/L | S | N2 | 33683565 | ||||||||
| Caenorhabditis elegans | 12.500000000000000 | umol/L | NS | N2 | 33683565 | Inactive | |||||||
| Caenorhabditis elegans | 12.500000000000000 | umol/L | S | N2 | 33683565 | ||||||||
| Caenorhabditis elegans | 25.000000000000000 | umol/L | 28.500000000000000 | 50.000000000000000 | S | N2 | 33683565 | Active | |||||
| Caenorhabditis elegans | 150.000000000000000 | ug/mL | 7.300000000000000 | NS | N2 | 33683565 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | 28.500000000000000 | 50.000000000000000 | 1 | 6 |